NCT03896568
- Conditions
- Astrocytoma, Glioblastoma, Glioma, +13 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Clinical trial condition
Recurrent Malignant Glioma
Explore clinical trials studying Recurrent Malignant Glioma. Study availability and eligibility vary by location and protocol.
24 public trials
3 recruiting studies
Recurrent Malignant Glioma trial results
NCT05278208
- Conditions
- Anaplastic Ependymoma, Brain Diseases, Brain Neoplasms, +32 more
- Locations
-
- Children's Hospital Colorado Aurora, Colorado, United States
- Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States
- Nationwide Children's Hospital Columbus, Ohio, United States
- Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States
NCT06964737
- Conditions
- Glioma, Neoplasms, Neoplasms by Histologic Type, +11 more
- Locations
-
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
Not yet recruiting
FPS-ZM1 With or Without Dexamethasone for Controlling Post Operative Cerebral Edema in Patients With Glioblastoma
NCT07791264
- Conditions
- Astrocytoma, Glioblastoma, Glioma, +10 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
NCT07481721
- Conditions
- Glioma, Neoplasms, Neoplasms by Histologic Type, +6 more
- Locations
-
- National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Beijing, Beijing Municipality, China
Active, not recruiting
Erdafitinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With FGFR Mutations (A Pediatric MATCH Treatment Trial)
NCT03210714
- Conditions
- Advanced Malignant Solid Neoplasm, Central Nervous System Neoplasms, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +74 more
- Locations
-
- Children's Hospital of Alabama Birmingham, Alabama, United States
- Providence Alaska Medical Center Anchorage, Alaska, United States
- Banner Children's at Desert Mesa, Arizona, United States
- Banner University Medical Center - Tucson Tucson, Arizona, United States
Active, not recruiting
Chimeric Antigen Receptor (CAR) T Cells With a Chlorotoxin Tumor-Targeting Domain for the Treatment of MMP2+ Recurrent or Progressive Glioblastoma
NCT04214392
- Conditions
- Astrocytoma, Glioblastoma, Glioma, +11 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
Active, not recruiting
Pembrolizumab (MK-3475) in Patients With Recurrent Malignant Glioma With a Hypermutator Phenotype
NCT02658279
- Conditions
- Glioma, Neoplasms, Neoplasms by Histologic Type, +6 more
- Locations
-
- University of California, Los Angeles Los Angeles, California, United States
- University of California San Francisco San Francisco, California, United States
- University of Miami Miami, Florida, United States
- Massachusetts General Hospital Boston, Massachusetts, United States
Active, not recruiting
Selpercatinib for the Treatment of Advanced Solid Tumors, Lymphomas, or Histiocytic Disorders With Activating RET Gene Alterations, a Pediatric MATCH Treatment Trial
NCT04320888
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Ependymoma, Female Urogenital Diseases, +85 more
- Locations
-
- Children's Hospital of Alabama Birmingham, Alabama, United States
- Providence Alaska Medical Center Anchorage, Alaska, United States
- Banner Children's at Desert Mesa, Arizona, United States
- Phoenix Childrens Hospital Phoenix, Arizona, United States
Active, not recruiting
Savolitinib in Treating Patients With Recurrent or Refractory Primary CNS Tumors
NCT03598244
- Conditions
- Brain Diseases, Brain Neoplasms, Brain Stem Neoplasms, +25 more
- Locations
-
- Children's Hospital Los Angeles Los Angeles, California, United States
- Lucile Packard Children's Hospital Stanford University Palo Alto, California, United States
- Children's Hospital Colorado Aurora, Colorado, United States
- Children's National Medical Center Washington D.C., District of Columbia, United States